EMORY UNIVERSITY;THE UNITED STATES OF AMERICA represented by the UNITED STATES DEPARTMENT OF VETERANS AFFAIRS
发明人:
Shanthi Srinivasan
申请号：
US15003324
公开号：
US10052362B2
申请日:
2016.01.21
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The disclosure relates to therapeutic methods for regulating weight gain, metabolic syndrome, and insulin resistance. In certain embodiments, the disclosure relates to methods of treating or preventing obesity, metabolic syndrome, or insulin resistance by administering an effective amount of a pharmaceutical composition comprising one or more GDNF receptor agonists to a subject in need thereof.
